| 000 | 01855 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517214809.0 | ||
| 264 | 0 | _c20190715 | |
| 008 | 201907s 0 0 eng d | ||
| 022 | _a1747-4132 | ||
| 024 | 7 |
_a10.1080/17474124.2018.1476137 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEl Kassas, Mohamed | |
| 245 | 0 | 0 |
_aAn account of the real-life hepatitis C management in a single specialized viral hepatitis treatment centre in Egypt: results of treating 7042 patients with 7 different direct acting antiviral regimens. _h[electronic resource] |
| 260 |
_bExpert review of gastroenterology & hepatology _cDec 2018 |
||
| 300 |
_a1265-1272 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Observational Study | ||
| 650 | 0 | 4 |
_aAntiviral Agents _xadverse effects |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aEgypt _xepidemiology |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHepacivirus _xdrug effects |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aProgram Evaluation |
| 650 | 0 | 4 | _aSustained Virologic Response |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aAlboraie, Mohamed | |
| 700 | 1 | _aOmran, Dalia | |
| 700 | 1 | _aSalaheldin, Mohamed | |
| 700 | 1 | _aWifi, Mohamed Naguib | |
| 700 | 1 | _aElBadry, Mohamed | |
| 700 | 1 | _aEl Tahan, Adel | |
| 700 | 1 | _aEzzat, Sameera | |
| 700 | 1 | _aMoaz, Enass | |
| 700 | 1 | _aFarid, Amir M | |
| 700 | 1 | _aOmar, Heba | |
| 700 | 1 | _aAbouelkhair, Mahmoud | |
| 700 | 1 | _aAfify, Shimaa | |
| 700 | 1 | _aElsaeed, Kadry | |
| 700 | 1 | _aShazly, Yehia | |
| 700 | 1 | _aDoss, Wahid | |
| 700 | 1 | _aEsmat, Gamal | |
| 773 | 0 |
_tExpert review of gastroenterology & hepatology _gvol. 12 _gno. 12 _gp. 1265-1272 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/17474124.2018.1476137 _zAvailable from publisher's website |
| 999 |
_c28387852 _d28387852 |
||